The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments
FDA Law Blog
SEPTEMBER 20, 2021
Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Finally, FDA will hold a public workshop on meeting management.
52 
Let's personalize your content